<DOC>
	<DOC>NCT01680107</DOC>
	<brief_summary>The purpose of this study is to determine whether d-cycloserine augments the clinical effects of exposure-based cognitive-behaviour therapy for panic disorder.</brief_summary>
	<brief_title>D-cycloserine Augmented CBT for Panic Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Panic Disorder</mesh_term>
	<mesh_term>Cycloserine</mesh_term>
	<criteria>clinical diagnosis of panic disorder at least moderate agoraphobic avoidance psychoactive medication last 6 weeks exposurebased cognitivebehaviour treatment for panic disorder and agoraphobia during last 3 months female participant who is pregnant or breastfeeding lifetime history of psychosis, bipolar disorder, alcohol, medication or drug abuse or dependence; current primary depressive disorder lifetime history of epilepsy or other significant disease or disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>d-cycloserine, cognitive-behaviour therapy, panic disorder</keyword>
</DOC>